This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: National Health Research Institutes, National Taiwan University, National Yang Ming Chiao Tung University. Active years: 2018-2025.
Company Filing History:
5 out of 189 
5 out of 1,391 
5 out of 1,244 Years Active: 2018-2025
Title: Innovations of Wen-Sung Lai
Introduction
Wen-Sung Lai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of neurological research through his innovative inventions. With a total of 5 patents, his work focuses on developing novel compounds that can aid in the treatment and prevention of neurological disorders.
Latest Patents
One of his latest patents includes the invention of substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors. This invention provides novel substituted benzimidazole derivatives that are utilized as DAAO inhibitors, which can be beneficial in treating and preventing neurological disorders. This innovative approach highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Wen-Sung Lai has worked with various institutions, including National Taiwan University. His research and inventions have garnered attention in the scientific community, showcasing his expertise and dedication to innovation.
Collaborations
Wen-Sung Lai has collaborated with several professionals in his field, including Yufeng Jane Tseng and Yu-Li Liu. These collaborations have contributed to the development of his patents and have enhanced the impact of his work in the realm of neurological research.
Conclusion
Wen-Sung Lai's contributions to the field of neurological research through his innovative patents demonstrate his significant role as an inventor. His work continues to pave the way for advancements in medical treatments and therapies.